These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25024341)

  • 21. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies against gangliosides in patients with dementia.
    Hatzifilippou E; Koutsouraki E; Costa VG; Baloyannis SJ
    Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):660-6. PubMed ID: 24838532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
    J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndrome.
    van Sorge NM; Yuki N; Koga M; Susuki K; Jansen MD; van Kooten C; Wokke JH; van de Winkel JG; van der Pol WL; van den Berg LH
    J Neuroimmunol; 2007 Jan; 182(1-2):177-84. PubMed ID: 17156858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
    Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
    J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-ganglioside antibodies in patients with Guillain Barré syndrome and other neurological disorders.
    Vaishnavi C; Behura C; Prabhakar S; Sharma A; Kharbanda P
    Indian J Med Microbiol; 2013; 31(2):177-9. PubMed ID: 23867676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-GM1/GD1a complex antibodies in GBS sera specifically recognize the hybrid dimer GM1-GD1a.
    Mauri L; Casellato R; Ciampa MG; Uekusa Y; Kato K; Kaida K; Motoyama M; Kusunoki S; Sonnino S
    Glycobiology; 2012 Mar; 22(3):352-60. PubMed ID: 21921061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Guillain-Barré syndrome].
    Koga M; Yuki N
    Ryoikibetsu Shokogun Shirizu; 2000; (31):35-8. PubMed ID: 11269101
    [No Abstract]   [Full Text] [Related]  

  • 32. Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited.
    Yuki N; Yanaka C; Sudo M; Funakoshi M; Ishida H; Mori M; Kanda F; Hirata K
    J Neuroimmunol; 2014 Jul; 272(1-2):62-6. PubMed ID: 24841627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibodies to GM1 and GQ1b gangliosides].
    Obayashi H; Saida T; Fukui M; Hasegawa G; Nakamura N; Yoshikawa T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():653-5. PubMed ID: 16111360
    [No Abstract]   [Full Text] [Related]  

  • 34. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates.
    Pestronk A; Choksi R
    Neurology; 1997 Nov; 49(5):1289-92. PubMed ID: 9371910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands.
    Ang CW; Koga M; Jacobs BC; Yuki N; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2001 Dec; 121(1-2):83-7. PubMed ID: 11730944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome.
    Lardone RD; Yuki N; Irazoqui FJ; Nores GA
    Sci Rep; 2016 Jan; 6():19901. PubMed ID: 26818965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
    Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
    Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiganglioside GM1 antibodies and their complement activating capacity in central and peripheral nervous system disorders and in controls.
    Uetz-von Allmen E; Sturzenegger M; Rieben R; Rihs F; Frauenfelder A; Nydegger UE
    Eur Neurol; 1998; 39(2):103-10. PubMed ID: 9520071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.